For instance, CASP3 can control the development of AML1-ETO-driven leukemia in a ULK1-dependent manner [30]; TP53 is a well-recognized tumor suppressor gene and mutated TP53 serves as a regulatory factor and target of tumor autophagy [31]. This evidence concerns the gene RUNX1 and neoplasm.